Viewing Study NCT00030966


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2026-01-27 @ 6:00 AM
Study NCT ID: NCT00030966
Status: COMPLETED
Last Update Posted: 2009-06-18
First Post: 2002-02-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
Sponsor: Biogen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module